ATE357520T1 - Biologisches material zur behandlung eines säugetieres durch transfer einesfür einen antikörper kodierendes gen und eine pharmazeutische zusammensetzungdie diese enthält - Google Patents

Biologisches material zur behandlung eines säugetieres durch transfer einesfür einen antikörper kodierendes gen und eine pharmazeutische zusammensetzungdie diese enthält

Info

Publication number
ATE357520T1
ATE357520T1 AT98903075T AT98903075T ATE357520T1 AT E357520 T1 ATE357520 T1 AT E357520T1 AT 98903075 T AT98903075 T AT 98903075T AT 98903075 T AT98903075 T AT 98903075T AT E357520 T1 ATE357520 T1 AT E357520T1
Authority
AT
Austria
Prior art keywords
mammal
biological material
transfer
gene
nucleic acid
Prior art date
Application number
AT98903075T
Other languages
English (en)
Inventor
Marc Piechaczyk
Daniele Noel
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE357520T1 publication Critical patent/ATE357520T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT98903075T 1997-01-20 1998-01-16 Biologisches material zur behandlung eines säugetieres durch transfer einesfür einen antikörper kodierendes gen und eine pharmazeutische zusammensetzungdie diese enthält ATE357520T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9700540A FR2758569B1 (fr) 1997-01-20 1997-01-20 Materiel biologique pour le traitement d'un mammifere par transfert de gene d'anticorps et composition pharmaceutique le concernant
PCT/FR1998/000081 WO1998031808A1 (fr) 1997-01-20 1998-01-16 Materiel biologique pour le traitement d'un mammifere par transfert de gene d'anticorps et composition pharmaceutique le contenant

Publications (1)

Publication Number Publication Date
ATE357520T1 true ATE357520T1 (de) 2007-04-15

Family

ID=26233268

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98903075T ATE357520T1 (de) 1997-01-20 1998-01-16 Biologisches material zur behandlung eines säugetieres durch transfer einesfür einen antikörper kodierendes gen und eine pharmazeutische zusammensetzungdie diese enthält

Country Status (8)

Country Link
EP (1) EP0966532B1 (de)
AT (1) ATE357520T1 (de)
DE (1) DE69837380T2 (de)
DK (1) DK0966532T3 (de)
ES (1) ES2285755T3 (de)
FR (1) FR2758569B1 (de)
PT (1) PT966532E (de)
WO (1) WO1998031808A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6261281B1 (en) 1997-04-03 2001-07-17 Electrofect As Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
FR2784997A1 (fr) * 1998-10-22 2000-04-28 Transgene Sa Materiel biologique pour la preparation de compositions pharmaceutiques destinees au traitement de mammiferes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990006997A1 (en) * 1988-12-13 1990-06-28 United States Government As Represented By The Secretary Of The Department Of Health And Human Services Genetically engineered endothelial cells and use thereof
FR2706486B1 (fr) * 1993-06-16 1995-09-01 Rhone Poulenc Rorer Sa Séquences nucléiques, vecteurs les contenant, compositions pharmaceutiques et utilisations thérapeutiques.

Also Published As

Publication number Publication date
FR2758569B1 (fr) 1999-04-02
PT966532E (pt) 2007-06-29
EP0966532B1 (de) 2007-03-21
EP0966532A1 (de) 1999-12-29
DK0966532T3 (da) 2007-07-30
DE69837380D1 (de) 2007-05-03
ES2285755T3 (es) 2007-11-16
FR2758569A1 (fr) 1998-07-24
WO1998031808A1 (fr) 1998-07-23
DE69837380T2 (de) 2007-11-29

Similar Documents

Publication Publication Date Title
Nygren et al. Myeloid and lymphoid contribution to non-haematopoietic lineages through irradiation-induced heterotypic cell fusion
Friedman et al. Phenotypic and genotypic analysis of a human medulloblastoma cell line and transplantable xenograft (D341 Med) demonstrating amplification of c-myc
Tsumanuma et al. Allogeneic transplantation of periodontal ligament-derived multipotent mesenchymal stromal cell sheets in canine critical-size supra-alveolar periodontal defect model
DE69125824T2 (de) Analytischer marker für krebs, besonders für bösartigen brustkrebs
ZA958444B (en) Biological active proteins
KR950700075A (ko) 항-이알비비(erbB)-2 모노클로날항체의 조합물 및 그 사용방법
DE68925226D1 (de) Monoklonale Antikörper
Thesleff Epithelial cell rests of Malassez bind epidermal growth factor intensely
MXPA02008239A (es) Gen humano de la esquizofrenia.
WO1997026322A3 (en) Methods and compositions for inhibiting hexokinase
ATE524542T1 (de) Aus knochenmarksstützzellen stammende schwann'sche zellen
FI982745A0 (fi) TIE-2-reseptoriligandit (TIE-ligandi-3; TIE-ligandi-4) ja niiden käyttö
BR9707994A (pt) Adenovírus recombinantes defectivo composição farmacêutica utilização do adenovirus composição e processo de preparação de células t citotóxicas especificas de um antigene tumoral
Zhao et al. Stimulating factors and origins of precursor cells in traumatic heterotopic ossification around the temporomandibular joint in mice
RU95120165A (ru) Лекарственный препарат иммунозамещающего действия на основе клеточной суспензии и способ лечения синдрома приобретенного иммунодефицита (вич-инфекции) с использованием этого препарата
ATE310828T1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
DE69837380D1 (de) Biologisches material zur behandlung eines säugetieres durch transfer einesfür einen antikörper kodierendes gen und eine pharmazeutische zusammensetzungdie diese enthält
Ochareon et al. Growing the mandible: role of the periosteum and its cells
ATE276364T1 (de) Biologisches material zur herstellung pharmazeutischer zusammensetzungen zur behandlung von säugetieren
DE69535091D1 (en) Humane prostacyclinsynthase
Dieckmann-Schuppert et al. Echinococcus multilocularis: in vitro secretion of antigen by hybridomas from metacestode germinal cells and murine tumor cells
Yao et al. Effect of mesenchymal stem cell-incorporated hydroxyapatite-collagen scaffold on tissue repair in acute spinal cord injury, and the mechanism involved
IWASAKI et al. Intracranial Embryonal Carcinoma mixed with Endodermal Sinus Tumor and Teratomatous Elements in the Anterior Third Ventricle—Case Report—
ATE298244T1 (de) Monoklonaler antikörper mit selektiver bindung an vgf und verwendung zur behandlung von vgf- erkrankungen
WO2003066877A3 (en) Compositions and methods relating to hepatic specific genes and proteins

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0966532

Country of ref document: EP